Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 286 participants.
Also called NCT02145104
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 286 participants
- Sponsor
- Registry
-
NCT02145104
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02145104. Randomized; double masking; primary purpose treatment. Start 2014-06-17 (actual); primary completion 2016-06-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
Record details
- Record id
cardio:ct-nct02145104- Content hash
11c5ff9d1b74e2f3c63fbe4c43bad2d68646b32fe091689e5418b2e66c992360